AMLX: Amylyx Pharmaceuticals, Inc. Stock

by  •  • Comments Off on AMLX: Amylyx Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 338.46
Enterprise Value ($M) 261.07
Book Value ($M) 164.76
Book Value / Share 1.86
Price / Book 2.05
NCAV ($M) 160.56
NCAV / Share 1.81
Price / NCAV 2.11

Profitability (mra)
Return on Invested Capital (ROIC) -1.81
Return on Assets (ROA) -0.72
Return on Equity (ROE) -0.93

Liquidity (mrq)
Quick Ratio 6.67
Current Ratio 6.67

Balance Sheet (mrq) ($M)
Current Assets 189.43
Assets 193.63
Liabilities 28.87
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 87.37
Operating Income -291.88
Net Income -301.74
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -167.65
Cash from Investing 75.65
Cash from Financing 0.35

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Perceptive Advisors Llc 7.90 51.93
02-14 13G/A Panacea Innovation Ltd 2.60 -47.62
01-14 13G Point72 Asset Management, L.P. 5.60 50.52
11-12 13G/A Vanguard Group Inc 4.53 0.00
08-26 13G TCG Crossover GP II, LLC 6.80
07-08 13G/A BlackRock, Inc. 3.90 -33.30

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-04 10-K Form 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 206,589 652,103 31.68
2025-04-16 118,364 461,764 25.63
2025-04-15 100,993 358,758 28.15
2025-04-14 575,889 1,456,300 39.54

(click for more detail)

Similar Companies
ALNY – Alnylam Pharmaceuticals, Inc. ALXO – ALX Oncology Holdings Inc.
AMGN – Amgen Inc. AMPH – Amphastar Pharmaceuticals, Inc.
AMRX – Amneal Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io